Onconetix
ONCO
3 hedge funds and large institutions have $2.13M invested in Onconetix in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
4.64% less ownership
Funds ownership: 17.15% → 12.51% (-4.6%)
40% less funds holding
Funds holding: 5 → 3 (-2)
47% less capital invested
Capital invested by funds: $4.03M → $2.13M (-$1.9M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFG
American Financial Group
Cincinnati,
Ohio
|
+$641K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$1.47M |
| 2 |
Renaissance Technologies
New York
|
-$214K |
| 3 |
Jane Street
New York
|
-$37K |
| 4 |
Squarepoint
New York
|
-$29K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$24K |
ONCO Hedge Fund Activity: Q4 2022 in Review
3 of the 6,240 institutional investors tracked by Wall St. Rank reported a position in Onconetix (ONCO) for Q4 2022, worth a combined $2.13M — down 47% from $4.03M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ONCO and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was American Financial Group, adding an estimated $641K. The largest seller was Armistice Capital, exiting entirely with an estimated $1.47M sold.
- 3 institutional investors held Onconetix (ONCO) as of Q4 2022, down from 5 in Q3 2022.
- Funds reported $2.13M of Onconetix stock for Q4 2022, down 47% quarter-over-quarter.
- 0 funds opened new Onconetix positions in Q4 2022 and 2 closed out, a net change of -2 holders.
- The largest Onconetix buyer in Q4 2022 was American Financial Group, an estimated $641K added.
- The largest Onconetix seller in Q4 2022 was Armistice Capital, an estimated $1.47M sold.
Based on aggregated 13F filings for Q4 2022.